Tel Aviv University

Biosense, Inc.

Uri Oron

Hana Tuby

Avraham Matcovitch

Dan Frenkel

Dorit Farfara

Methods and systems are provided for delivering visible or infrared biostimulatory energy to bone marrow to subjects having or developing Alzheimer's disease. The radiation is delivered to sites remote from the brain at a dose sufficient to cause stimulated mesenchymal stem cells to appear in the brain and degrade &#x3b2;-amyloid. The energy may be coherent light and can be administered transcutaneously, subcutaneously, or via an intramedullary probe.

Low level laser therapy for Alzheimer's disease

Methods and systems () are provided for administering phototherapy to an injured tissue in a living subject by delivering visible or infrared biostimulatory energy to bone marrow at a dose sufficient to cause mesenchymal stem cells to appear in the injured tissue. The energy may be coherent light and can be administered transcutaneously, subcutaneously, or via an intramedullary probe (). The technique is useful for treating many types of tissue injury, including ischemic cardiac and renal conditions.

Low-level energy laser therapy

Low level laser therapy for alzheimer's disease

Methods and apparatus for biostimulation of a myocardial tissue, by irradiating the myocardial tissue with a source of electromagnetic radiation which causes biostimulation of the myocardial tissue. Preferably, the electromagnetic radiation is selected from the group consisting of infrared, visible light and ultraviolet radiation. Typically, the tissue is irradiated after the myocardial tissue develops an infarct of a given size, such that irradiating the myocardial tissue causes a reduction in the size of the infarct. The irradiation may also cause regeneration of cardiomyocytes in the infarct and help to preserve structure and activity of mitochondria in cardiomyocytes in the infarct.

Electromagnetic cardiac biostimulation

A method of treating a patient's heart comprises the steps of identifying an ischemic area of the heart. A plurality of cells are provided and the cells are irradiated in vitro with electromagnetic radiation. The irradiated cells are then implanted into the ischemic area of the heart. The electromagnetic radiation provides biostimulation of the cells. The treated cells are cardio myocetes such as from embrionic heart muscle or skeletal muscle cells. The electromagnetic radiation is in the infrared (IR) range, visible light range, or ultraviolet (UV) range.

Growing community of inventors

Rishon Lezion, Israel

Uri Oron